Economic Burden of Recurrence Among Resected Medicare Patients With Early Stage NSCLC

Economic Burden of Recurrence Among Resected Medicare Patients With Early Stage NSCLC

Introduction: Patients with early NSCLC (eNSCLC) who experience recurrence are associated with worse survival outcomes, but the economic burden of recurrence is not well characterized. This study evaluated the incremental health care resource utilization and costs of recurrence in Medicare patients...

Full description

Bibliographic Details
Main Authors: Jay M. Lee, MD, Rongrong Wang, MPH, Ann Johnson, MMSc, Sarika Ogale, PhD, Matthew Kent, MS, Janet S. Lee, PharmD, PhD
Format: Article
Language:English
Published: Elsevier 2023-04-01
Series:JTO Clinical and Research Reports
Subjects:
Early non–small cell lung cancer
Health economics
Healthcare resource utilization
Costs
Immunotherapy
Online Access:http://www.sciencedirect.com/science/article/pii/S2666364323000267

Internet

http://www.sciencedirect.com/science/article/pii/S2666364323000267

Similar Items